Cowen Starts Sophia Genetics SA (SOPH) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month highs with Hormuz crossings, Russian sanctions waiver in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Cerebras Systems falls as TD Cowen cuts price target
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- Nvidia wins CPU business from Modal, previously exclusive to AMD and Intel
UPDATE: Credit Suisse Starts Sophia Genetics SA (SOPH) at Outperform
August 17, 2021 4:27 AM EDT(Updated - August 17, 2021 4:43 AM EDT)
Credit Suisse analyst Katie Tryhane initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Outperform rating and a price target of $22.00.
The analyst comments "SOPH is a healthcare technology company offering a decentralized software platform that leverages... More
JPMorgan Starts Sophia Genetics SA (SOPH) at Overweight
August 17, 2021 4:20 AM EDTJPMorgan analyst Tycho W. Peterson initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Sophia Genetics SA... More
UPDATE: Morgan Stanley Starts Sophia Genetics SA (SOPH) at Overweight
August 17, 2021 3:31 AM EDT(Updated - August 17, 2021 4:41 AM EDT)
Morgan Stanley analyst Tejas Savant initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $24.00.
The analyst comments "Riding on the coattails of healthcare digitization, SOPHs differentiated... More



